
ICON Public Limited Company – NASDAQ:ICLR
ICON Public Limited Company stock price today
ICON Public Limited Company stock price monthly change
ICON Public Limited Company stock price quarterly change
ICON Public Limited Company stock price yearly change
ICON Public Limited Company key metrics
Market Cap | 17.11B |
Enterprise value | 21.68B |
P/E | 35.43 |
EV/Sales | 2.80 |
EV/EBITDA | 15.90 |
Price/Sales | 2.22 |
Price/Book | 2.02 |
PEG ratio | 0.20 |
EPS | 8.3 |
Revenue | 8.23B |
EBITDA | 1.71B |
Income | 683.11M |
Revenue Q/Q | 5.65% |
Revenue Y/Y | 5.29% |
Profit margin | 6.53% |
Oper. margin | 10.27% |
Gross margin | 28.6% |
EBIT margin | 10.27% |
EBITDA margin | 20.79% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeICON Public Limited Company stock price history
ICON Public Limited Company stock forecast
ICON Public Limited Company financial statements
$350.6
Potential upside: 95.85%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 2.02B | 115.59M | 5.72% |
---|---|---|---|
Sep 2023 | 2.05B | 163.66M | 7.96% |
Dec 2023 | 2.06B | 216.41M | 10.47% |
Mar 2024 | 2.09B | 187.43M | 8.97% |
2022-11-02 | 2.94 | 3 |
---|---|---|
2023-02-23 | 3.05 | 3.13 |
2023-04-27 | 2.9 | 2.9 |
Jun 2023 | 17107660000 | 8.31B | 48.58% |
---|---|---|---|
Sep 2023 | 17031497000 | 8.07B | 47.4% |
Dec 2023 | 16989863000 | 7.74B | 45.61% |
Mar 2024 | 17048251000 | 7.61B | 44.67% |
Jun 2023 | 203.88M | -40.61M | -172.76M |
---|---|---|---|
Sep 2023 | 341.51M | -35.49M | -258.66M |
Dec 2023 | 429.16M | -120.60M | -247.14M |
Mar 2024 | 327.07M | -39.36M | -263.69M |
ICON Public Limited Company alternative data
Sep 2023 | 41,160 |
---|---|
Oct 2023 | 41,160 |
Nov 2023 | 41,150 |
Dec 2023 | 41,150 |
Jan 2024 | 41,150 |
Feb 2024 | 41,150 |
Mar 2024 | 41,100 |
Apr 2024 | 41,100 |
May 2024 | 41,150 |
Jun 2024 | 41,150 |
Jul 2024 | 41,150 |
ICON Public Limited Company other data
Quarter | Transcript |
---|---|
Q1 2024 25 Apr 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 22 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 26 Oct 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 27 Jul 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Dr. Steven A. Cutler (1960) Chief Executive Officer & Director | $2,210,000 |
Mr. Brendan Brennan (1979) Chief Financial Officer | $914,000 |
ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued?
GreensKeeper Q1 2025 Portfolio Update
Baron Small Cap Fund: Q4 2024 Top Contributors And Detractors
Fortrea: Turning Around As The Activists Move In
ICON: A High Probability Of Success In The Uncertain R&D Process
ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)
Medpace: Clear Winner If China Blockade Succeeds
ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?
ICON: Starting Valuations And Business Returns Are 2 Major Hurdles
-
What's the price of ICON Public Limited Company stock today?
One share of ICON Public Limited Company stock can currently be purchased for approximately $179.01.
-
When is ICON Public Limited Company's next earnings date?
Unfortunately, ICON Public Limited Company's (ICLR) next earnings date is currently unknown.
-
Does ICON Public Limited Company pay dividends?
No, ICON Public Limited Company does not pay dividends.
-
How much money does ICON Public Limited Company make?
ICON Public Limited Company has a market capitalization of 17.11B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.89% to 8.12B US dollars. ICON Public Limited Company earned 612.34M US dollars in net income (profit) last year or $2.9 on an earnings per share basis.
-
What is ICON Public Limited Company's stock symbol?
ICON Public Limited Company is traded on the NASDAQ under the ticker symbol "ICLR".
-
What is ICON Public Limited Company's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of ICON Public Limited Company?
Shares of ICON Public Limited Company can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ICON Public Limited Company's key executives?
ICON Public Limited Company's management team includes the following people:
- Dr. Steven A. Cutler Chief Executive Officer & Director(age: 65, pay: $2,210,000)
- Mr. Brendan Brennan Chief Financial Officer(age: 46, pay: $914,000)
-
How many employees does ICON Public Limited Company have?
As Jul 2024, ICON Public Limited Company employs 41,150 workers, which is 0% more then previous quarter.
-
When ICON Public Limited Company went public?
ICON Public Limited Company is publicly traded company for more then 27 years since IPO on 15 May 1998.
-
What is ICON Public Limited Company's official website?
The official website for ICON Public Limited Company is iconplc.com.
-
How can i contact ICON Public Limited Company?
ICON Public Limited Company can be reached via phone at +353 1 291 2000.
-
What is ICON Public Limited Company stock forecast & price target?
Based on 3 Wall Street analysts` predicted price targets for ICON Public Limited Company in the last 12 months, the avarage price target is $350.6. The average price target represents a 95.85% change from the last price of $179.01.
ICON Public Limited Company company profile:

ICON Public Limited Company
iconplc.comNASDAQ
42,250
Medical - Diagnostics & Research
Healthcare
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Dublin, 18
CIK: 0001060955
ISIN: IE0005711209
CUSIP: G4705A100